2025-03-28 18:50:39
Latest Post
Maithan A1loys Limited purchases 1.99 lakh shares of NSE
Lancor Holdings Ltd updates on new projects
Scheme of amalgamation of Cohance Lifesciences into and with Suven Pharmaceuticals has been sanctioned by NCLT
AstraZeneca Pharma India Ltd to discontinue the manufacturing and marketing of Imdur from April 1, 2025
Aerolloy Technologies secures major order from Safran Aircraft Engines for LEAP Engine Cast Components
Stock Report
Integrated Proteins Ltd Q4FY24 at Rs. 2.21 lakhs
Posted On : 2024-04-27 21:54:59( TIMEZONE : IST )
has reported Standalone financial results for the period ended March 31, 2024.
Financial Results (Q4 FY2024) - QoQ Comparison
The company has reported total income of Rs. 0.3688 crores during the period ended March 31, 2024 as compared to Rs. 0.0392 crores during the period ended December 31, 2023.
The company has posted net profit / (loss) of Rs. 0.0221 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 0.0813 crores for the period ended December 31, 2023.
The company has reported EPS of Rs. 0.06 for the period ended March 31, 2024 as compared to Rs. 0.23 for the period ended December 31, 2023.
| Financials | Q4 FY2024 | Q3 FY2024 | % Change |
| Total Income | ₹ 0.3688 crs | ₹0.0392 crs |  840.82% |
| Net Profit | ₹0.0221 crs | ₹0.0813 crs |  -72.82% |
| EPS | ₹0.06 | ₹0.23 | -73.91% |
Financial Results (Q4 FY2024) - YoY Comparison
The company has reported total income of Rs. 0.3688 crores during the period ended March 31, 2024 as compared to Rs.0.2066 crores during the period ended March 31, 2023.
The company has posted net profit / (loss) of Rs.0.0221 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.0.0352 crores for the period ended March 31, 2023.
The company has reported EPS of Rs.0.06 for the period ended March 31, 2024 as compared to Rs.0.10 for the period ended March 31, 2023.
| Financials | Q4 FY2024 | Q4 FY2023 | % Change |
| Total Income | ₹ 0.3688 crs | ₹0.2066 crs | 78.51% |
| Net Profit | ₹0.0221 crs | ₹0.0352 crs | -37.22% |
| EPS | ₹0.06 | ₹0.10 | -40.00% |
Financial Results (Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.0.4863 crores during the Financial Year ended March 31, 2024 as compared to Rs.0.3231 crores during the Financial Year ended March 31, 2023.
The company has posted net profit / (loss) of Rs.0.0893 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.0.0309 crores for the Financial Year ended March 31, 2023.
The company has reported EPS of Rs.0.25 for the Financial Year ended March 31, 2024 as compared to Rs.0.09 for the Financial Year ended March 31, 2023.
| Financials | Year Ended FY2024 | Year Ended FY2023 | % Change |
| Total Income | ₹0.4863 crs | ₹0.3231 crs | 50.51% |
| Net Profit | ₹0.0893 crs | ₹0.0309 crs | 189.00% |
| EPS | ₹0.25 | ₹0.09 | 177.78% |
